Stray Dog

Palantir's NHS contract extended, then re-tendered

  • Mixed: The £330 million NHS contract will be extended, then re-tendered against domestic rivals, so the extension only buys time.
  • Mixed: AmeriLife is rolling out Foundry and AIP, but no amount was disclosed and only one use case is in production.
  • Neutral: A director sold about $250,000 of stock under a pre-set 10b5-1 plan, which carries no signal.
Read the full notes

The £330 million NHS Federated Data Platform contract is to be extended (without triggering the break clause) while a new tender goes out in which Palantir will compete with domestic alternatives.

Read more

Near-term revenue is safe, and the switching-cost moat is real with government customers, but an extension only buys time and does not mean the relationship is secure. Public pressure in the UK (the Corporate Accountability campaign and Al Jazeera's critical report on battlefield data in Ukraine) is still building. The NHS contract is small on an annualised basis, so the main effect is on the demonstration value for European government markets. The AmeriLife deal is another 'pilot to production to company-wide rollout' example and fits the pilot-conversion path described on the earnings call, but no amount was disclosed and only one use case, at Crump, is in production so far. Director Lauren Friedman sold about $250,000 of stock under a pre-set 10b5-1 plan, which carries no signal.

Key evidence

  • The UK government plans to extend the £330 million NHS Federated Data Platform contract without triggering the break clause, and is preparing a new tender in which Palantir competes with domestic alternatives (FT, 5 Nov)
  • An industry briefing says an operational assessment concluded that moving off the platform would cause serious disruption (second-hand, original not verified). The switching-cost moat is real with government customers
  • Corporate Accountability has launched a campaign against the contract, and Al Jazeera ran a critical report on battlefield data in Ukraine on 5 Nov, adding to public pressure in the UK
  • AmeriLife is deploying Foundry and AIP across its Health and Wealth businesses. Its subsidiary Crump moved into production after a pilot, connecting to its case-management and back-office platform ACE (joint announcement, Palantir IR, 5 Nov)
  • AmeriLife reports a distribution network of more than 325,000 agents and advisers and 160 marketing organisations
  • The pilot-conversion path matches what was said on the earnings call, and the deal is an expansion example within the US commercial customer count (686, up 5% QoQ)
Show 2 more
  • Director Lauren Friedman sold 1,358 shares on 2 Nov, code S (open-market sale), at an average of $186.29, about $250,000. The sale was under a pre-set 10b5-1 plan, and the shares were held by a family gift trust (Form 4, filed 4 Nov)
  • This is the only new Form 4 since 30 Oct

Catalysts to watch

  • Result of the new NHS tender (domestic alternatives vs Palantir), which sets the direction of the demonstration effect in European government markets
  • How UK public and political pressure develops (the Corporate Accountability campaign, the Al Jazeera report, parliamentary attention)
  • Timetable for AmeriLife to extend from the single Crump use case to the whole group
  • Continued growth in the US commercial customer count (currently 686, up 5% QoQ)

Risks

  • A domestic alternative wins the NHS re-tender, damaging the demonstration effect in European government markets
  • UK public pressure keeps building and the issue becomes politicised (the Al Jazeera report on battlefield data in Ukraine is already out)
  • No amount disclosed for the AmeriLife deal, only one use case (Crump) in production, and the group-wide rollout not yet delivered
  • The second-hand claim that moving off the platform would cause serious disruption is not verified against the original and cannot be treated as hard evidence

Sources 4

  1. Financial Times (5 Nov): UK government extends £330 million NHS contract and prepares a new tender
  2. Palantir Investor Relations (5 Nov): AmeriLife joint announcement
  3. Al Jazeera (5 Nov): critical report on battlefield data in Ukraine
  4. SEC Form 4 (filed 4 Nov): Lauren Friedman sold 1,358 shares on 2 Nov, code S